Advancing biotech from discovery to clinic with expertise in oncology, gene therapy, translational planning, and IND strategy
Advancing biotech from discovery to clinic with expertise in oncology, gene therapy, translational planning, and IND strategy
Regulatory roadmaps and submission support tailored to each program’s scientific and translational profile. We help teams anticipate FDA feedback and align packages with current guidance.
Design IND-enabling studies in cells and humanized mouse models, including toxicology, biodistribution, and efficacy — all planned with FDA expectations in mind.
Develop efficient, compliant clinical trial protocols for oncology and gene therapy programs, aligning operational feasibility with regulatory rigor.
Integrate biomarker selection, AI-assisted analysis, and translational endpoints to strengthen regulatory and clinical outcomes.
We support biotech teams in communicating their science with clarity and purpose, from early discovery to IND and first-in-human studies.
Services:
• Publication strategy
• Abstracts, posters, grant and manuscripts
• Scientific storytelling
• Translational and biomarker content
• Regulatory-aligned scientific writing
We are the only consulting firm in Texas focused exclusively on early-stage oncology and gene therapy translation bridging academic discovery and IND readiness. Our team merges scientific, translational, and regulatory insight into one cohesive solution.
Texas-first, nationally scalable. We anchor in the Houston/TMC ecosystem and extend through partnerships with CROs, accelerators, and translational networks.
Where others offer advice, we deliver execution.
Clarity, compliance, and collaboration at every stage of translation.
This framework advances every program toward FDA submission efficiently and confidently.
We help innovators move their discoveries closer to patients. Let’s start the conversation.
Houston, TX, USA
Open today | 09:00 am – 05:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.